The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor
- 29 June 2020
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 30 (12) , 6593-6602
Abstract
Objectives To compare the diagnostic accuracy of dynamic contrast-enhanced phases, hepatobiliary phase (HBP), and diffusion-weighted imaging (DWI) for the detection of liver metastases from neuroendocrine tumor (NET). Methods Sixty-seven patients with suspected NET liver metastases underwent gadoxetic acid–enhanced MRI. Three radiologists read four imaging sets separately and independently: DWI, T2W+dynamic, T2WI+HBP, and DWI+HBP. Reference standard included all imaging, histological findings, and clinical data. Sensitivity and specificity were calculated and compared for each imaging set. Interreader agreement was evaluated by intraclass correlation coefficient (ICC). Univariate logistic regression was performed to evaluate lesion characteristics (size, ADC, and enhancing pattern) associated to false positive and negative lesions. Results Six hundred twenty-five lesions (545 metastases, 80 benign lesions) were identified. Detection rate was significantly higher combining DWI+HBP than the other imaging sets (sensitivity 86% (95% confidence interval (CI) 0.845–0.878), specificity 94% (95% CI 0.901–0.961)). The sensitivity and specificity of the other sets were 82% and 65% for DWI, 88% and 69% for T2WI, and 90% and 82% for HBP+T2WI, respectively. The interreader agreement was statistically higher for both HBP sets (ICC = 0.96 (95% CI 0.94–0.97) for T2WI+HBP and ICC = 0.91 (95% CI 0.87–0.94) for DWI+HBP, respectively) compared with that for DWI (ICC = 0.76 (95% CI 0.66–0.83)) and T2+dynamic (ICC = 0.85 (95% CI 0.79–0.9)). High ADC values, large lesion size, and hypervascular pattern lowered the risk of false negative. Conclusion Given the high diagnostic accuracy of combining DWI+HBP, gadoxetic acid–enhanced MRI is to be considered in NET patients with suspected liver metastases. Fast MRI protocol using T2WI, DWI, and HBP is of interest in this population. Key Points • The combined set of diffusion-weighted (DW) and hepatobiliary phase (HBP) images yields the highest sensitivity and specificity for neuroendocrine liver metastasis (NELM) detection. • Gadoxetic acid should be the contrast agent of choice for liver MRI in NET patients. • The combined set of HBP and DWI sequences could also be used as a tool of abbreviated MRI in follow-up or assessment of treatment such as somatostatin analogs.Keywords
This publication has 48 references indexed in Scilit:
- Gastroenteropancreatic neuroendocrine tumours: an overviewBritish Journal of Nursing, 2016
- Gastroenteropancreatic Neuroendocrine Tumors: Role of Imaging in Diagnosis and ManagementRadiology, 2013
- ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown PrimaryNeuroendocrinology, 2012
- NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine TumorPancreas, 2010
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Detection of Liver Metastases From Endocrine Tumors: A Prospective Comparison of Somatostatin Receptor Scintigraphy, Computed Tomography, and Magnetic Resonance ImagingJournal of Clinical Oncology, 2005
- MR Imaging of Hepatic Metastases Caused by Neuroendocrine Tumors: Comparing Four TechniquesAmerican Journal of Roentgenology, 2003
- Islet Cell Tumor of the Pancreas: Biphasic CT versus MR Imaging in Tumor DetectionRadiology, 2000
- MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.American Journal of Roentgenology, 1995
- Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms.American Journal of Roentgenology, 1995